Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics [Phase 4]
Phase 4 trial evaluating paliperidone palmitate in schizophrenia patients previously unsuccessfully treated with oral antipsychotics has com…
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of ALKS 9072 (aripiprazole lauroxil; ARISTADA) in adults with schizophrenia; results …
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders [NA]
The Life Goals Collaborative Care trial evaluating health outcomes in mental disorders has completed, with results posted on Jan 22, 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression [NA]
This entry notes the completion of a clinical trial investigating the neuropsychobiological correlates of sex-steroid hormone manipulation i…
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism [Phase 3]
Phase 3 clinical trial evaluating acamprosate in patients with schizophrenia and comorbid alcoholism has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Social Cognitive Training for Psychosis: Treatment Development [Phase 1]
Phase 1 study of Social Cognitive Training for Psychosis for schizophrenia/psychosis has been completed. The results will inform next steps …
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Treatment Development Targeting Severe and Persistent Negative Symptoms [NA]
This update describes a completed clinical trial from UT Health San Antonio focused on developing treatments for severe, persistent negative…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia [Phase 1]
Phase 1 SPECT study investigating the NMDA receptor system in healthy volunteers and patients with schizophrenia; the trial has been termina…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Lurasidone Low-Dose - High-Dose Study Study [Phase 3]
Phase 3 trial comparing low-dose versus high-dose lurasidone in schizophrenia completed; results were posted in January 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain
A completed trial from Creighton University investigated whether vitamin D supplementation influences weight gain associated with atypical a…
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes
This clinical trial update describes a completed study on genetic research in schizophrenia using DNA markers and clinical phenotypes, with …
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Shared Decision Making for Patients With First-admission Schizophrenia [Phase 2, Phase 3]
An update on a Phase 2/Phase 3 trial evaluating shared decision making for patients with first-admission schizophrenia; the Yokohama City Un…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Efficacy of Pregnenolone in Patients With Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating pregnenolone for efficacy in schizophrenia and schizoaffective disorder has completed. The study was spo…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating culturally based family therapy to improve treatment outcomes for …
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study
This observational study describes real-world use of quetiapine extended-release in France for schizophrenia and bipolar disorder, summarizi…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects [NA]
This clinical trial evaluates the effect of memantine on event-related potentials in individuals with early schizophrenia and in healthy con…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Regulation of Arginine-vasopressin (AVP) [NA]
Completed Yale-sponsored clinical trial studying the regulation of arginine-vasopressin (AVP) in schizophrenia and depression.
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: The Effect of Paliperidone Palmitate in Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating paliperidone palmitate for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating resveratrol's effects on cardiovascular risk markers and cognitive performance in patients with schizoph…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Switching From Consta® to Sustenna® in Patients With Schizophrenia
This clinical trial update reports the completion of a study evaluating switching from Risperdal Consta to Invega Sustenna in patients with …
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia [Phase 3]
A Phase 3 head-to-head trial comparing aripiprazole once-monthly and paliperidone palmitate in adults with schizophrenia, with results poste…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia [Phase 3]
A Phase 3 clinical trial update showing results for brexpiprazole in adults with acute schizophrenia; results were posted in December 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia [Phase 3]
A Phase 3 efficacy study of OPC-34712 in adults with schizophrenia has completed and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia [NA]
An open-label pilot trial evaluated alpha-lipoic acid for weight loss in individuals with schizophrenia. The study has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Lifestyle Modification for Weight Loss in Schizophrenia [NA]
A Yale University-sponsored clinical trial update reports the completion of a study evaluating lifestyle modification for weight loss in ind…